Artículos de revistas
High risk cytogenetic abnormalities in patients with multiple myeloma Características citogenéticas y detección de anormalidades de alto riesgo en mieloma múltiple
Fecha
2019Registro en:
Revista Medica de Chile, Volumen 147, Issue 1, 2019, Pages 61-64
07176163
00349887
10.4067/S0034-98872019000100061
Autor
Legües, María Eugenia
Morales, Paulina
Valenzuela, Mercedes
Encina, Andrea
Martí, María José
Bascuñán, Claudia
Cornejo, Paulina
Peña, Camila
Undurraga, María Soledad
Institución
Resumen
Background: Cytogenetic abnormalities observed in the bone marrow of patients with multiple myeloma (MM) are an important prognostic factor for risk stratification. Aim: To investigate karyotype characteristics and frequency of the high-risk cytogenetic abnormalities t(4;14), t(14;16) and del(17p) in Chilean patients with MM. Material and Methods: We studied 30 patients with MM by conventional cytogenetics (CC) and fluorescent in situ hybridization of plasma cells selected using cytoplasmic immunoglobulin staining (cIg-FISH). Results: Overall, the two techniques in combination allowed us to identify clonal genetic abnormalities in 47% of patients. The t(4;14) abnormality was observed in 19% of patients, del(17p) was observed in 10% of patients, and t(14;16) was not detected. Conclusions: Our results showed frequencies of high-risk abnormalities similar to those reported abroad. Cytogenetic studies should be performed routinely f